Friday, October 08, 2004

Some Good News About Treating MS 54% fall in relapse rate, 76% of MS patients have no disease progression with REBIF®. Sustained Efficacy of Rebif® Further Demonstrated in Long Term Data from PRISMS Study Presented at the 20th ECTRIMS Congress Patients with relapsing-remitting multiple sclerosis (RRMS) who were on placebo and then treated with Rebif® in the PRISMS study showed substantial clinical benefits with a 54% relative reduction in relapse rate, Serono announced at the 20th congress of the European Committee for Treatment and Research In Multiple Sclerosis (ECTRIMS) meeting in Vienna, Austria... click link for more info. [Medical News Today] 2:53:58 PM    comment [] Skipping drugs because of cost One in 6 chronically ill adults skip prescription drugs due to cost. Skimping most common among those who pay the most out-of-pocket, earn the least, or don't have prescription drug coverageA recent nationally representative survey of older adults finds that 18 percent of those with chronic conditions such as heart disease and depression skip some of their prescription medicines because of out-of-pocket cost pressures, and 14 percent do so at least every month... click link for more info. [Medical News Today] 7:15:34 AM    comment [] Cash and Counseling PA Receives Grant to Help Seniors, Disabled Gain Autonomy, Better Quality of Life. $250,000 Grant Will Replicate Successful Cash & Counseling Program [Medicare/ Medicaid News from myHealthcareNews.com] 7:13:35 AM    comment [] Senior Survey on Medicare Drug Benefit Survey of Seniors Reveals that Proposed New Medicare Drug Benefit Conflicts With Seniors' Priorities. As Public Comment to Centers for Medicare & Medicaid Services Closes, Seniors Call for Broad Access to Medications, Informed Appeal Process [Insurance/ Managed Care News from myHealthcareNews.com] 7:12:36 AM    comment []

© Copyright 2006 Norman G. DeLisle, Jr.. Last update: 8/7/2006; 10:25:29 AM.